A Study Explore WJB001 Capsules in Patients With Advanced Solid Tumors

NCT05773820 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

210

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: WJB001

Sponsor

Wigen Biomedicine Technology (Shanghai) Co., Ltd.

Collaborators

[object Object]